Financials
Financial year 2025
Worth noting
- A loss two years in a row.
Gross margin
€ -1.5 million
▼ 24% vs 2024
Profit
Caution€ -4.3 million
▼ 18% vs 2024
Debts
Low€ 1.5 million
▼ 32% vs 2024
XEOS MEDICAL from Gent, company number BE0738435957, closed financial year 2025 with a result of € -4.3 million after tax. For that financial year XEOS MEDICAL recorded a gross margin of € -1.5 million and equity of € 4 million. Compared with financial year 2024, the result moved from € -3.7 million to € -4.3 million. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 27, 2026.
What happened at XEOS MEDICAL?
What happened at XEOS MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Patrick Keereman stepped down as director. NBB
- Guido Van der Schueren stepped down as director. NBB
- Walter Mastelinck stepped down as director. NBB
- Dr. Vincent Keereman, Neurologie BV stepped down as director. NBB
- Lloyd Diamond stepped down as director. NBB
- X-square BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 4.3 million. Source: NBB ↗
- X-square BV became a director. NBB
In short
From € 2 million loss in 2021 to € 4.3 million loss in 2025.
Paid € 10,070 in corporate taxes since 2021.
A new publication or filing at XEOS MEDICAL? We notify you, reason included.
Follow XEOS MEDICALNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of Xeos Medical Inc itself.
Directors
According to the 2025 annual accounts
since 2019 · until 2031
Guido Van der Schueren
Director
Also active at: eXplio, KEYWARE SMART CARD DIVISION, POWERGRAPH +4 more
since 2019 · until 2031
since 2019 · until 2031
Dr. Vincent Keereman, Neurologie BV
Director · represented by Vincent Keereman
Also active at: CLOUDS OF CARE
since 2024 · until 2031
Lloyd Diamond
Director
since 2024 · until 2031
since 2025 · until 2031
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 1084 box 301
9051 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 11 companies are registered at this address.
CANTILLANA
€ 33.8 million revenue · 2025
NUTRIPHYT
€ 2.4 million gross margin · 2025
Cantillana Group
Erudite.Health
€ -485,799 gross margin · 2025
Fire Engineered Solutions
€ 2.7 million gross margin · 2025
+6 more
Details
- Company number
- 0738.435.957
- VAT number
- BE 0738.435.957
- Registered office
- Kortrijksesteenweg 1084 bus 301, 9051 Gent
- Names & denominations
- XEOS MEDICAL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 26 November 2019
- Peppol
- Active · Active since 29 Jul 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten
Overige vormen van onderwijs